Close Menu

simulation

GNS Healthcare will apply its AI and simulation technology to data from the CoMMpass study in search of insights on disease progression and drug response.

Two research groups concluded that a one-pulse model for Neanderthal-human mixing does not explain present ancestry patterns in East Asians. 

The algorithm, which was developed by researchers at MIT and validated by a team at Novartis, lets users identify regions on antibodies that are prone to aggregation and then predict mutations to improve the stability of biotherapeutic formulations.

The firm will use its REFS platform to create in silico network models that will be used in simulations that connect drug doses to transcriptional and imaging measurement networks.

There has “been a tremendous shift towards using regulatory, integrative genomic, and kinetic models to understand the biology of drug development [and] disease and using modeling and simulation to predict what the cell is doing.”

Simbios will use physical simulations to understand how drugs work and to study how neural activity ultimately generates movement.

In Print: Apr 14, 2009

Premium

Microarray-Related Papers of Note Published in March 2009

The company will use the hospital's cancer clinical and genetic data to develop technologies for glioblastoma diagnostics or treatments.

Pfizer La Jolla Incubator, Chromocell, NJEDA Biotechnology Development Center, Wockhardt USA LLC, Acorda Therapeutics, Eastman Business Park, Qatar Science & Technology Park, and more…

The goal of the project is to build a dynamic model of liver function in rats and humans that will account for effects of genetic variations and other variables, such as patient gender, age, behavioral traits, and environmental factors.

Pages

The Lancet has made changes to its peer-review process in response to its recent retraction of a COVID-19-related paper, Science reports.

The New York Times reports that a series of emails show how Department of Health and Human Services officials sought to silence the Centers for Disease Control and Prevention.

A new initiative aims to move Australia's genome sequencing labs onto one system, the Sydney Morning Herald reports.

In PLOS this week: recessive mutation tied to early-onset dilated cardiomyopathy, epigenetic analysis of lung adenocarcinoma, and more.